European Medicines Agency consultation: Draft guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

The European Medicines Agency has published a Draft guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture (EMA/CHMP/BWP/68803/2010).

The document is available on the following webpage:

http://www.ema.europa.eu/pdfs/human/bwp/6880310en.pdf

The scope of this draft guideline is to provide guidance for the isolation on cell culture of any potential influenza vaccine virus intended for cell culture or egg-based influenza vaccine manufacture.

Your comments on this document are most welcomed by 01 September 2010 to the address elisa.pedone@ema.europa.eu.

Please kindly use the template in the link below to submit your comments:

http://www.ema.europa.eu/pdfs/human/regaffair/submitcomment.doc

We would be grateful if you could disseminate this e-mail to anyone else who might be interested in this document.